Melanoma Stem Cells
Melanoma Stem Cells - Related Videos
05:40
Melanoma Stem Cell Isolation: A Method to Obtain CD133 Positive and Negative Melanoma Cells Using Magnetic-activated Cell Sorting
0 Views •
2023
This video describes the technique of isolating CD133 negative and positive melanoma stem cells from a primary melanoma cell line using magnetic-activated cell sorting. The CD133 positive melanoma CSCs are further studied to understand the mechanisms of melanoma tumorigenesis.
12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
0 Views •
Cited by 22 •
2013
This article describes the preparation of freshly obtained melanoma tissue into primary cell cultures, and how to remove contaminations of erythrocytes and fibroblasts from the tumor cells. Finally, we describe how CD133+ putative melanoma stem cells are sorted from the CD133- bulk using Magnetic Activated Cell Sorting (MACS).
10:03
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
0 Views •
Cited by 6 •
2016
The goal of this protocol is to show the protocol for reprogramming melanoma tumor-infiltrating lymphocytes into induced pluripotent stem cells.
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
0 Views •
Cited by 15 •
2014
Evaluated in syngeneic immunocompetent hosts, cancer stem cell (CSC) based dendritic cell (DC) vaccine demonstrated significantly higher antitumor immunity than traditional DC vaccines pulsed with heterogeneous bulk tumor cells.
03:52
Experimental Metastatic Melanoma Mouse Model: A Platform to Study the Metastatic Potential of Melanoma Cells in the Lungs
0 Views •
2023
In this video, melanoma cells are intravenously injected through the tail vein in the mouse model. The melanoma cells further travel through the circulatory system, adapting to the distant microenvironment and causing metastasis in organs like lungs.
FAQs
Self-renewal preserves a stem-like melanoma cell population, while asymmetric division can produce one cell that retains these properties and another that enters a different tumor cell state. Together, these processes support continued tumor maintenance while generating cellular diversity. This balance helps explain how melanoma can remain adaptable rather than consisting of a single, uniform population.
Plasticity allows melanoma stem cells to adapt to changing microenvironments by shifting among tumor cell states. That flexibility can support metastasis and may help cells withstand targeted therapies or immunotherapies. As a result, researchers study plasticity not only as a feature of tumor diversity, but also as a mechanism that may contribute to treatment failure and disease recurrence.
Their ability to self-renew, divide asymmetrically, and differentiate into diverse tumor cell states creates variation within the same melanoma. This intratumoral heterogeneity means that tumor cells may not respond identically to environmental changes or treatment. Understanding how stem-like populations generate this diversity is therefore important for explaining progression and for designing strategies that address more than one tumor state.
Research on these cells can reveal characteristics associated with tumor initiation, persistence, plasticity, metastasis, or treatment resistance. Such characteristics may help identify biomarkers that distinguish persistent tumor-initiating populations from other melanoma cells. In cancer research, these biomarkers could improve understanding of disease progression and help investigators evaluate whether therapies affect the populations most relevant to recurrence.
Rapidly proliferating melanoma cells are only one component of the tumor. Persistent tumor-initiating populations may sustain the disease, repopulate the tumor, and contribute to recurrence after treatment. The melanoma stem cell concept therefore supports therapeutic strategies that consider both actively expanding cells and less readily eliminated populations, including cells associated with resistance to targeted therapies or immunotherapies.
They provide a framework for examining how melanoma progresses, adapts to its microenvironment, spreads, and returns after treatment. Investigators can also use this focus to connect cellular behaviors such as self-renewal and differentiation with clinically important outcomes, including metastasis and therapy resistance. These questions link tumor biology to the development of more comprehensive treatment approaches.